following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv). .
understanding cholesterol effects of adalimumab by new techniques was another goal of gelfand and mehta's study. .
.ai-based software may help predict risk of dementia